TY - JOUR
T1 - Hidradenitis Suppurativa
T2 - Diagnosis and Management in the Emergency Department
AU - Okun, Martin M.
AU - Flamm, Avram
AU - Werley, Elizabeth Barrall
AU - Kirby, Joslyn S.
N1 - Funding Information:
Noah Goldfarb, MD provided critical review of the manuscript. Steven Daveluy, MD provided the photographs in Figures 3B and 3C. Chris Sayed, MD provided the photographs in Figure 4.
Publisher Copyright:
© 2022 The Authors
PY - 2022/11
Y1 - 2022/11
N2 - Background: Hidradenitis suppurativa (HS) is a chronic immune-mediated inflammatory skin disease characterized by abscesses and inflammatory nodules, and occasionally tunnels and scars, in the axillae, groin, and inframammary areas. Objective: HS can be challenging to diagnose because it mimics localized soft-tissue infection. The process of differentiating HS from soft-tissue infection is discussed. Patients with HS frequently visit emergency departments (EDs) for acute management of pain and drainage from HS lesions. This review updates emergency and urgent care physicians on how to educate and initiate treatment for patients with HS, and to coordinate care with dermatologists and other physicians early in their disease course. Discussion: Recent updates on the epidemiology, diagnosis, and management of HS are reviewed. Conclusions: Practice variations between how care for HS is provided in the ED setting and what HS treatment guidelines recommend are identified.
AB - Background: Hidradenitis suppurativa (HS) is a chronic immune-mediated inflammatory skin disease characterized by abscesses and inflammatory nodules, and occasionally tunnels and scars, in the axillae, groin, and inframammary areas. Objective: HS can be challenging to diagnose because it mimics localized soft-tissue infection. The process of differentiating HS from soft-tissue infection is discussed. Patients with HS frequently visit emergency departments (EDs) for acute management of pain and drainage from HS lesions. This review updates emergency and urgent care physicians on how to educate and initiate treatment for patients with HS, and to coordinate care with dermatologists and other physicians early in their disease course. Discussion: Recent updates on the epidemiology, diagnosis, and management of HS are reviewed. Conclusions: Practice variations between how care for HS is provided in the ED setting and what HS treatment guidelines recommend are identified.
UR - http://www.scopus.com/inward/record.url?scp=85143788627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143788627&partnerID=8YFLogxK
U2 - 10.1016/j.jemermed.2022.08.001
DO - 10.1016/j.jemermed.2022.08.001
M3 - Article
C2 - 36243614
AN - SCOPUS:85143788627
SN - 0736-4679
VL - 63
SP - 636
EP - 644
JO - Journal of Emergency Medicine
JF - Journal of Emergency Medicine
IS - 5
ER -